Career Development Program (CDP)

Leader: Lawrence Kirschner, MD, PhD; Co-Leader: Robert Gagel, MD

The CDP is led by two senior translational researchers who have demonstrated major commitments to academic education and mentorship in leadership positions within their home institutions. Dr. Lawrence Kirschner, the CDP Leader at OSU, is the Associate Director of the MD, PhD Program at Ohio State, is past Director of the Endocrinology Fellowship director, and has served on the Department of Internal Medicine Internship, College of Medicine Curriculum Development Committee, and Institutional Graduate Medical Education committee. The Co-Leader at MDACC, Dr. Robert Gagel, is currently the Head of the Division of Internal Medicine and prior to that as the Chairman of the Endocrine Department at MDACC. He has mentored a large number of young postdoctoral researchers, clinical fellows, and young faculty members. Both of these individuals are committed to recruiting and supporting new investigators to enter thyroid cancer translational research as well as supporting established investigators from other areas interested in moving into the thyroid cancer field. Both are experienced grant reviewers and effectively have administered large programs within their own institutions, thus both are highly qualified leaders for the CDP. There will be interaction and involvement with CTSA programs at both institutions, which provide additional training for grant writing and provide lectures and materials for young faculty members. 

Career Development Award

The Ohio State University and M.D. Anderson Cancer Center Thyroid Cancer SPORE (PI: Matthew Ringel, MD) is currently soliciting applications to be considered for: Career Development Projects (CDP).

The Career Development Award seeks to support individuals interested in pursuing a research career focused on improving the diagnosis or treatment of thyroid tumors through translational research. Translational research is defined as clinical or basic research where the focus is translation to a patient care activity. Funds from this program will support advanced post-doctoral and clinical fellows (transitioning to a faculty position), junior faculty, or established investigators who wish to develop or refocus their careers on translational research in thyroid cancer. Junior investigators must include a written description of a clearly defined mentorship program, and a letter of commitment from both the applicant’s department chairman and a designated mentor, and have no current or previous NIH R01 or equivalent funding. Established investigators must include a written description clearly outlining the proposed shift in research focus, a letter of support of this goal by their Division and Department Chair and document no current or previous NIH R01 or equivalent funding or established focus in thyroid cancer.

All applicants must hold either an MD or PhD degree or equivalent, and hold a faculty appointment OR a documented offer for a faculty appointment with a start date in 2014-2015. Proposals should include justification for one year of funding. There may be potential for an additional year of funding for awardees, depending on project progress, available funds and recommendation of the CDP review committee. Promising results of current awardees and an expanded research plan may be submitted as a competitive renewal application. All applicants are required to submit proposals electronically in PDF format. Applications that do not adhere to the guidelines will not be reviewed.

OSU and MDACC are equal opportunity/affirmative action employers. Women, minorities, veterans and individuals with disabilities are encouraged to apply. The NCI SPORE program places special emphasis on recruiting qualified women and minorities. Final recommendations for funding will be made by the OSU-MDACC Thyroid Cancer SPORE Executive Committee.

APPLICATION FORMAT: (11 pt – Arial or Times Roman, 1/2-inch margins)

  • Application cover page
  • Preliminary Budget and Budget Justification: 1 page. CDP SPORE funds may be used for salary and/or research support appropriate to the proposal (note that equipment is not an allowable expense)
  • Biographical Sketch and Other Support for PI and co-investigators (NIH format)
  • Scientific proposal: Two-page research proposal (NIH format), outlining research plans for a two-year period.
  • Literature Cited
  • One to two page description of career goals and interests in thyroid cancer translational research including relevant past experience
  • Letters of Support (maximum of 1 page each) from the proposed mentor and Division and/or Department Chair.

APPROXIMATE FUNDING LEVELS (for one year): $50,000 (direct costs)

Recommendation for funding projects will be based on the following criteria:

  • scientific merit;
  • technical soundness;
  • innovation;
  • potential translation of research to or from clinical application;
  • multidisciplinary interaction;
  • potential impact on reducing thyroid cancer incidence/morbidity/mortality rate or improving quality of life of thyroid tumor patients; and
  • appropriateness of the proposed budget.

Applications must be submitted electronically as a PDF attachment via e-mail to by Monday, June 9, 2014.

Anticipated Start Date: Friday, August 1, 2014

Inquiries should be directed as follows: Nanci Edgington, Thyroid Cancer Research Program, 560 TMRF, 420 West 10th Ave., Columbus, OH 43210-1240, Telephone: (614) 292-1621, Facsimile: (614) 292-1622, E-Mail:


The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 460 W. 10th Avenue, Columbus, OH 43210 Phone: 1-800-293-5066 | Email: